Effect of iron supplementation on psychomotor development of non-anaemic, exclusively or predominantly breastfed infants: a randomised, controlled trial

Anna Chmielewska, Grzegorz Chmielewski, Magnus Domellöf, Zbigniew Lewandowski, Hania Szajewska, Anna Chmielewska, Grzegorz Chmielewski, Magnus Domellöf, Zbigniew Lewandowski, Hania Szajewska

Abstract

Introduction: Uncertainty exists regarding the effects of iron supplementation during infancy on neurodevelopmental outcomes in the absence of anaemia. The aim of the study is to establish whether psychomotor and mental development is influenced by early iron supplementation in healthy, non-anaemic, exclusively or predominantly breastfed infants.

Methods and analysis: Healthy term infants will be recruited. If exclusively or predominantly breast fed (>50% of daily feedings) and not anaemic at 4 months, they will be randomised to receive either iron pyrophosphate (approximately 1 mg/kg) or placebo daily until 9 months of age. The primary outcome measure is neurodevelopment assessed with the Bayley Scales of Infant and Toddler Development (Bayley-III) at 12 months, and repeated at 24 and 36 months of age. Haematological parameters of iron metabolism also will be measured.

Ethics and dissemination: The Bioethics Committee of the Medical University of Warsaw approved the study protocol before recruitment started. Study results will be submitted to peer-reviewed journals in the fields of paediatrics and nutrition, and presented at relevant conferences.

Trial registration number: NCT02242188.

Keywords: RCT; children; iron.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

References

    1. McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr 2007;85:931–45.
    1. Beard J. Iron deficiency alters brain development and functioning. J Nutr 2003;133(Suppl 1):1468S–72S.
    1. Lozoff B. Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction. J Nutr 2011;141:740S–6S. 10.3945/jn.110.131169
    1. Lozoff B, Beard J, Connor J et al. . Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 2006;64(Suppl):S34–43. 10.1301/nr.2006.may.S34-S43
    1. Wang B, Zhan S, Gong T et al. . Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia. Cochrane Database Syst Rev 2013;6:CD001444 10.1002/14651858.CD001444.pub2
    1. Domellöf M, Braegger C, Campoy C et al. , ESPGHAN Committee on Nutrition. Iron requirements of infants and toddlers. J Pediatr Gastroenterol Nutr 2014;58:119–29. 10.1097/MPG.0000000000000206
    1. Aggett PJ, Agostoni C, Axelsson I et al. . Do we know enough? A commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2002;34:337–45. 10.1097/00005176-200204000-00003
    1. Beard J. Recent evidence from human and animal studies regarding iron status and infant development. J Nutr 2007;137:524S–30S.
    1. Shafir T, Angulo-Barroso R, Jing Y et al. . Iron deficiency and infant motor development. Early Hum Dev 2008;84:479–85. 10.1016/j.earlhumdev.2007.12.009
    1. Baker RD, Greer FR, Committee on Nutrition, American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics 2010;126:1040–105. 10.1542/peds.2010-2576
    1. Szajewska H, Ruszczynski M, Chmielewska A. Effects of iron supplementation in nonanemic pregnant women, infants and young children on the mental performance and psychomotor development of children: a systematic review of randomized controlled trials. Am J Clin Nutr 2010;91:1–7. 10.3945/ajcn.2009.28948
    1. Friel JK, Aziz K, Andrews WL et al. . A double-masked, randomized control trial of iron supplementation in early infancy in healthy term breast-fed infants. J Pediatr 2003;143:582–6. 10.1067/S0022-3476(03)00301-9
    1. Lind T, Lönnerdal B, Stenlund H et al. . A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development. Am J Clin Nutr 2004;80:729–36.
    1. Moffatt MEK, Longstaffe S, Besant J et al. . Prevention of iron deficiency and psychomotor decline in high risk infants through use of iron fortified infant formula: a randomized clinical trial. J Pediatr 1994;125:527–34. 10.1016/S0022-3476(94)70003-6
    1. Morley R, Abbott R, Fairweather-Tait S et al. . Iron fortified follow on formula from 9 to 18 months improves iron status but not development or growth: a randomized trial. Arch Dis Child 1999;81:247–52. 10.1136/adc.81.3.247
    1. Yalcin SS, Yurdakok K, Acikgoz D et al. . Short-term developmental outcome of iron prophylaxis in infants. Pediatr Int 2000;42:625–30. 10.1046/j.1442-200x.2000.01299.x
    1. Pongcharoen T, DiGirolamo AM, Ramakrishnan U et al. . Longterm effects of iron and zinc supplementation during infancy on cognitive function at 9 y of age in northeast Thai children: a follow-up study. Am J Clin Nutr 2011;93:636–43. 10.3945/ajcn.110.002220
    1. Abdullah K, Kendzerska T, Shah P et al. . Efficacy of oral iron therapy in improving the developmental outcome of preschool children with nonanaemic iron deficiency: a systematic review. Public Health Nutr 2013;16:1497–506. 10.1017/S1368980012003709
    1. Domellöf M, Cohen RJ, Dewey KG et al. . Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age. J Pediatr 2001;138:679–87. 10.1067/mpd.2001.112895
    1. Dewey KG, Domellöf M, Cohen RJ et al. . Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras. J Nutr 2002;132:3249–55.
    1. Mora JO. Iron supplementation: overcoming technical and practical barriers. J Nutr 2002;32:853S–5S.
    1. ; (accessed 02 Jul 2015).
    1. Hirve S, Bhave S, Bavdekar A et al. . Low dose ‘Sprinkles’— an innovative approach to treat iron deficiency anaemia in infants and young children. Indian Pediatr 2007;44:91–100.
    1. Bayley N. Bayley scales of infant and toddler development. 3rd edn San Antonio, TX: Pearson Education, Inc., 2006. ( (accesses 02 Jul 2015).
    1. Achenbach TM, Rescorla LA. Manual for the ASEBA preschool forms and profiles. Burlington, VT: University of Vermont, Research Center for Children, Youth and Families, 2000.
    1. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science 2012;338:768–72. 10.1126/science.1224577
    1. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep 2015;35:e00192 10.1042/BSR20150014
    1. Berglund S, Lonnerdal B, Westrup B et al. . Effects of iron supplementation on serum hepcidin and serum erythropoietin in low-birthweight infants. Am J Clin Nutr 2011;94:1553–61. 10.3945/ajcn.111.013938
    1. (accessed 15 Jul 2015).
    1. (accessed 1 Sep 2015).
    1. Armijo-Olivo S, Warren S, Magee D. Intention to treat analysis, compliance, drop-outs and how to deal with missing data in clinical research: a review. Phys Ther Rev 2009;14:36–49. 10.1179/174328809X405928
    1. Karlson CW, Rapoff MA. Attrition in randomized controlled trials for pediatric chronic conditions. J Pediatr Psychol 2009;34:782–93. 10.1093/jpepsy/jsn122

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera